184 related articles for article (PubMed ID: 21469091)
21. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
[TBL] [Abstract][Full Text] [Related]
22. High Thymic Output of Effector CD4
Zhao Y; Alard P; Kosiewicz MM
J Immunol Res; 2019; 2019():8785263. PubMed ID: 31281853
[TBL] [Abstract][Full Text] [Related]
23. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
24. T Regulatory Cells From Non-obese Diabetic Mice Show Low Responsiveness to IL-2 Stimulation and Exhibit Differential Expression of Anergy-Related and Ubiquitination Factors.
Godoy GJ; Olivera C; Paira DA; Salazar FC; Ana Y; Stempin CC; Motrich RD; Rivero VE
Front Immunol; 2019; 10():2665. PubMed ID: 31824482
[TBL] [Abstract][Full Text] [Related]
25. Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice.
Lepault F; Gagnerault MC
J Immunol; 2000 Jan; 164(1):240-7. PubMed ID: 10605017
[TBL] [Abstract][Full Text] [Related]
26. Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.
Scholzen A; Mittag D; Rogerson SJ; Cooke BM; Plebanski M
PLoS Pathog; 2009 Aug; 5(8):e1000543. PubMed ID: 19680449
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis.
Murawski MR; Litherland SA; Clare-Salzler MJ; Davoodi-Semiromi A
Ann N Y Acad Sci; 2006 Oct; 1079():198-204. PubMed ID: 17130555
[TBL] [Abstract][Full Text] [Related]
28. Antidiabetic and Immunoregulatory Activities of Extract of
Lin CH; Kuo YH; Shih CC
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373070
[TBL] [Abstract][Full Text] [Related]
29. Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment.
Bresson D; Fousteri G; Manenkova Y; Croft M; von Herrath M
J Autoimmun; 2011 Dec; 37(4):342-51. PubMed ID: 22063316
[TBL] [Abstract][Full Text] [Related]
30. Peripherally induced regulatory T cells contribute to the control of autoimmune diabetes in the NOD mouse model.
Schuster C; Jonas F; Zhao F; Kissler S
Eur J Immunol; 2018 Jul; 48(7):1211-1216. PubMed ID: 29604048
[TBL] [Abstract][Full Text] [Related]
31. IL-7 uniquely maintains FoxP3(+) adaptive Treg cells that reverse diabetes in NOD mice via integrin-β7-dependent localization.
Li CR; Deiro MF; Godebu E; Bradley LM
J Autoimmun; 2011 Nov; 37(3):217-27. PubMed ID: 21745722
[TBL] [Abstract][Full Text] [Related]
32. Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes.
Kerkvliet NI; Steppan LB; Vorachek W; Oda S; Farrer D; Wong CP; Pham D; Mourich DV
Immunotherapy; 2009 Jul; 1(4):539-47. PubMed ID: 20174617
[TBL] [Abstract][Full Text] [Related]
33. The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors.
D'Alise AM; Auyeung V; Feuerer M; Nishio J; Fontenot J; Benoist C; Mathis D
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19857-62. PubMed ID: 19073938
[TBL] [Abstract][Full Text] [Related]
34. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.
Long SA; Cerosaletti K; Bollyky PL; Tatum M; Shilling H; Zhang S; Zhang ZY; Pihoker C; Sanda S; Greenbaum C; Buckner JH
Diabetes; 2010 Feb; 59(2):407-15. PubMed ID: 19875613
[TBL] [Abstract][Full Text] [Related]
35. Combination Therapy Using IL-2/IL-2 Monoclonal Antibody Complexes, Rapamycin, and Islet Autoantigen Peptides Increases Regulatory T Cell Frequency and Protects against Spontaneous and Induced Type 1 Diabetes in Nonobese Diabetic Mice.
Manirarora JN; Wei CH
J Immunol; 2015 Dec; 195(11):5203-14. PubMed ID: 26482409
[TBL] [Abstract][Full Text] [Related]
36. Activation of the Aryl Hydrocarbon Receptor by 10-Cl-BBQ Prevents Insulitis and Effector T Cell Development Independently of Foxp3+ Regulatory T Cells in Nonobese Diabetic Mice.
Ehrlich AK; Pennington JM; Wang X; Rohlman D; Punj S; Löhr CV; Newman MT; Kolluri SK; Kerkvliet NI
J Immunol; 2016 Jan; 196(1):264-73. PubMed ID: 26573835
[TBL] [Abstract][Full Text] [Related]
37. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.
Huang H; Dawicki W; Zhang X; Town J; Gordon JR
J Immunol; 2010 Nov; 185(9):5003-10. PubMed ID: 20870943
[TBL] [Abstract][Full Text] [Related]
38. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P
Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
[TBL] [Abstract][Full Text] [Related]
39. Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) mice.
Zhao Y; Lin B; Darflinger R; Zhang Y; Holterman MJ; Skidgel RA
PLoS One; 2009; 4(1):e4226. PubMed ID: 19156219
[TBL] [Abstract][Full Text] [Related]
40. Age-dependent divergent effects of OX40L treatment on the development of diabetes in NOD mice.
Haddad CS; Bhattacharya P; Alharshawi K; Marinelarena A; Kumar P; El-Sayed O; Elshabrawy HA; Epstein AL; Prabhakar BS
Autoimmunity; 2016 Aug; 49(5):298-311. PubMed ID: 27245356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]